Stibophen
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Also known as: fuadin, stibofen
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Stibophen is a drug catalogued in DrugCentral. Recorded indications include Infection by Schistosoma.
- Indications: Infection by Schistosoma.
- ATC code: P02BX03 (Other antitrematodal agents).
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Infection by Schistosoma
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
P02BX03 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTHELMINTICS › ANTITREMATODALS › Other antitrematodal agents |
Chemical structure
| Molecular formula | — |
|---|---|
| Molecular weight | — |
| CAS number | — |
| InChIKey | — |
| PubChem CID | 16683008 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Stibophen used for?
DrugCentral lists the following indications for Stibophen: Infection by Schistosoma.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4712 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1788389 — compound record and bioactivity
- PubChem CID 16683008 — chemical identifiers
- DrugBank DB13236 — drug record
- FDA UNII 6CM08O30EH — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.